Crossref
CO160 DELAYED DIAGNOSIS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) AMONG PATIENTS TREATED WITH TAFAMIDIS
Value in Health · 2026-06 · 29 (6) · S53
DOI: 10.1016/j.jval.2026.03.255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Da Sol Kim und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kim, D. S., Fuerte, B., & Park, C. (2026). CO160 DELAYED DIAGNOSIS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) AMONG PATIENTS TREATED WITH TAFAMIDIS. Value in Health, 29(6), S53. https://doi.org/10.1016/j.jval.2026.03.255
Vancouver
Kim DS, Fuerte B, Park C. CO160 DELAYED DIAGNOSIS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) AMONG PATIENTS TREATED WITH TAFAMIDIS. Value in Health. 2026;29(6):S53. doi:10.1016/j.jval.2026.03.255
BibTeX
@article{Kim2026,
author = {Kim, Da Sol and Fuerte, Beverly and Park, Chanhyun},
title = {CO160 DELAYED DIAGNOSIS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) AMONG PATIENTS TREATED WITH TAFAMIDIS},
journal = {Value in Health},
year = {2026},
volume = {29},
number = {6},
pages = {S53},
doi = {10.1016/j.jval.2026.03.255}
}
EUVIMED